Ipca Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE571A01038
  • NSEID: IPCALAB
  • BSEID: 524494
INR
1,910.00
-19.05 (-0.99%)
BSENSE

Oct 09

BSE+NSE Vol: 97.07 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Ipca Labs
Gland Pharma
Emcure Pharma
Wockhardt
Glaxosmi. Pharma
Sai Life
Anthem Bioscienc
Abbott India
Biocon
Alkem Lab
Ajanta Pharma
Why is Ipca Laboratories Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.04 times
2
The company has declared Positive results for the last 7 consecutive quarters
  • ROCE(HY) Highest at 17.89%
  • INVENTORY TURNOVER RATIO(HY) Highest at 3.72 times
  • PAT(Q) At Rs 311.86 cr has Grown at 27.4% (vs previous 4Q average)
3
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 19-May-26 and has generated -4.78% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and OBV
4
High Institutional Holdings at 48.08%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Consistent Returns over the last 3 years
  • Along with generating 7.88% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Ipca Labs should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Ipca Labs for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Ipca Labs
42.72%
0.25
32.10%
Sensex
-11.8%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.18%
EBIT Growth (5y)
9.25%
EBIT to Interest (avg)
26.57
Debt to EBITDA (avg)
0.88
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.98
Tax Ratio
23.94%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
48.10%
ROCE (avg)
17.41%
ROE (avg)
11.91%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
35
Industry P/E
36
Price to Book Value
6.01
EV to EBIT
26.66
EV to EBITDA
21.54
EV to Capital Employed
6.26
EV to Sales
4.75
PEG Ratio
0.64
Dividend Yield
0.31%
ROCE (Latest)
20.33%
ROE (Latest)
14.93%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Mildly Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company
OPERATING CF(Y)

Highest at Rs 1,378.12 Cr

ROCE(HY)

Highest at 19.55%

DPS(Y)

Highest at Rs 6.00

CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 564.59 cr

DEBTORS TURNOVER RATIO(HY)

Highest at 4.79 times

NET SALES(Q)

Highest at Rs 2,788.10 cr

PBDIT(Q)

Highest at Rs 669.51 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 24.01%

PBT LESS OI(Q)

Highest at Rs 546.82 cr.

PAT(Q)

Highest at Rs 401.89 cr.

EPS(Q)

Highest at Rs 15.84

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Ipca Labs
Operating Cash Flow - Annually
Highest at Rs 1,378.12 Cr and Grown
each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 546.82 cr has Grown at 47.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 371.13 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 2,788.10 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 669.51 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 24.01%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 546.82 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 401.89 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 401.89 cr has Grown at 33.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 300.99 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 15.84
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Cash and Cash Equivalents - Half Yearly
Highest at Rs 564.59 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Highest at 4.79 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Dividend per Share (DPS) - Annually
Highest at Rs 6.00
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (Rs)